Stem Cells for Alzheimer’s: What Animal Studies Suggest and Why Human Proof Still Matters
Animal studies suggest MSCs may help Alzheimer’s pathways, but human trials still decide what is real.
Stem-Cell-Derived Dopamine Neurons and Parkinson’s: UCLA’s $9M Environmental Risk Study
UCLA will use stem-cell-derived dopamine neurons to study how pesticides and pollution may affect Parkinson’s risk.
Stem Cell Transplant for MS: What the BEAT-MS Trial Is Testing
The BEAT-MS trial is testing stem cell transplant for treatment-resistant MS. Here is what patients should know.
Stem Cells for Cerebral Palsy: What a New Randomized Trial Actually Found
A new randomized trial studied stem cells for cerebral palsy. Here is what it found, what it did not prove, and why it matters.
Stem Cell Therapy for Epilepsy: A 2026 Breakthrough in Seizure Control
Living with drug-resistant epilepsy means facing the constant, unpredictable threat of seizures. When medications fail, the remaining options often involve invasive brain surgery that can permanently affect memory and cognition. You might feel like you are out of options. But what if there was a way to restore balance to the brain without removing tissue? […]
Revolutionary Stem Cell Therapy Offers New Hope for Brain Injury Recovery
Are you struggling with the long-term effects of a concussion or traumatic brain injury? Do you worry that traditional treatments only mask symptoms without actually healing your brain? A groundbreaking discussion on the Broken Brains podcast reveals how stem cell therapy could transform brain injury treatment and offer real healing instead of temporary fixes. What Makes Stem […]
Federal Government Launches Ambitious “Moon Shot” to Repair Brain Damage with Stem Cells
A groundbreaking new program aims to develop stem cell treatments that could restore function to millions with brain injuries within five years The United States Department of Health and Human Services has announced one of the most ambitious medical research initiatives in recent memory: a program to develop stem cell treatments capable of repairing brain […]
NYSCF and Janssen Partner on Neurodegenerative Disease Drug Discovery
The New York Stem Cell Foundation Research Institute (NYSCF) and Janssen Research & Development, a Johnson & Johnson company, have partnered to accelerate the development of precision medicines for neurodegenerative diseases. NYSCF’s AI-powered platform, using automated stem cell systems, will be leveraged to identify new drug targets and therapies. This collaboration combines NYSCF’s expertise in stem cell […]
Revolutionizing Neurodegenerative Disease Treatment with Pluripotent Stem Cells: Insights from Sana Biotechnology
In an exciting development for the field of stem cell research, Sana Biotechnology has unveiled promising preclinical data in the prestigious journal, Nature Biotechnology. This data underscores the potential of pluripotent stem cell-derived human glial progenitor cells (hGPCs) in treating neurodegenerative diseases. Sana Biotechnology’s innovative approach focuses on harnessing the power of pluripotent stem cells, […]
Groundbreaking Down Syndrome Research at Heidelberg University Paves Way for Advanced Treatments
In a landmark collaboration, the European Wellness Biomedical Group (EWBG), alongside the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg University, has achieved significant breakthroughs in Down Syndrome research. This pioneering study leverages cutting-edge MRI methods to uncover a crucial link between cognitive abilities and brain volume changes in individuals with Down Syndrome, […]